These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2610359)

  • 21. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method.
    Qu X; Huang L; Burthart T; Crawford SE; Caplan MS; Hsueh W
    Prostaglandins; 1996 Apr; 51(4):249-62. PubMed ID: 8935185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine.
    Chignard M; Le Couedic JP; Coëffier E; Benveniste J
    Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
    Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet activating factor: an inhibitor of neutrophil activation?
    O'Donnell MC; Siegel JN; Fiedel BA
    Clin Exp Immunol; 1981 Jan; 43(1):135-42. PubMed ID: 7249391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor.
    Rylander R; Beijer L
    Am Rev Respir Dis; 1987 Jan; 135(1):83-6. PubMed ID: 3541718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
    Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological profile of 48740 R.P., a PAF-acether antagonist.
    Lefort J; Sedivy P; Desquand S; Randon J; Coëffier E; Maridonneau-Parini I; Floch A; Benveniste J; Vargaftig BB
    Eur J Pharmacol; 1988 Jun; 150(3):257-68. PubMed ID: 2843382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
    Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
    Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of paf-acether in human thymus.
    Salem P; Denizot Y; Pitton C; Dulioust A; Bossant MJ; Benveniste J; Thomas Y
    FEBS Lett; 1989 Oct; 257(1):49-51. PubMed ID: 2806565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-activating factor-induced calcium mobilization in human platelets and neutrophils: effects of PAF-acether antagonists.
    Selak MA; Smith JB
    J Lipid Mediat; 1989; 1(2):125-37. PubMed ID: 2519888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.
    Prancan A; Lefort J; Barton M; Vargaftig BB
    Eur J Pharmacol; 1982 May; 80(1):29-35. PubMed ID: 7095003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
    Terashita Z; Imura Y; Nishikawa K
    Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets.
    Shaw JO; Henson PM
    Am J Pathol; 1980 Mar; 98(3):791-810. PubMed ID: 6987890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation.
    Zhou W; Javors MA; Olson MS
    J Immunol; 1992 Sep; 149(5):1763-9. PubMed ID: 1506691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.
    Kloprogge E; Akkerman JW
    Biochem J; 1984 Nov; 223(3):901-9. PubMed ID: 6150705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell adhesion by membrane-bound paf-acether.
    Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
    Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG; Dusting GJ
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.